CUMBERLAND PHARMACEUTICALS (CPIX) Stock Income Statement
NASDAQ:CPIX - US2307701092 - Common Stock
3.52 USD
+0.03 (+0.86%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.07M | 37.87M | 39.55M | 42.01M | 35.98M | |||
| Minority Interest Expense | -5.90K | -36.10K | 51.50K | 79.80K | 95.20K | |||
| Cost Of Goods | 6.74M | 6.59M | 6.07M | 8.62M | 7.41M | |||
| Gross Profit | 35.34M | 31.28M | 33.49M | 33.39M | 28.57M | |||
| Operating Expenses | 38.33M | 37.71M | 39.70M | 38.60M | 34.85M | |||
| Research and Development | 5.36M | 4.82M | 5.83M | 6.69M | 5.68M | |||
| Selling, General, and Administrative Expenses | 28.42M | 28.00M | 28.93M | 26.58M | 24.56M | |||
| Operating Income | -2.99M | -6.43M | -6.21M | -5.20M | -6.28M | |||
| Interest Income/Expense | -205.00K | -271.10K | -381.00K | -487.60K | -72.00K | |||
| Other Income/Expense | N/A | 237.10K | 3.65M | 611.30K | 2.19M | |||
| Non Recurring Items | N/A | 0.00 | -3.34M | -500.00K | -1.40M | |||
| Income Before Taxes | -2.96M | -6.47M | -6.29M | -5.58M | -5.56M | |||
| Income Tax | -34.20K | -22.70K | 45.80K | 68.90K | 34.90K | |||
| Net Income | -2.93M | -6.48M | -6.28M | -5.57M | -3.51M | |||
| EBITDA | 2.83M | -389.10K | -440.30K | 123.20K | -1.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.21 | -0.46 | -0.44 | -0.38 | -0.23 | |||
| Non GAAP EPS | 0.14 | -0.08 | 0.18 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 83.99% | 82.61% | 84.66% | 79.48% | 79.40% | |||
| Profit Margin | -6.97% | -17.11% | -15.88% | -13.26% | -9.75% | |||
| Operating Profit Margin | -7.11% | -16.99% | -15.70% | -12.39% | -17.44% | |||
All data in USD